A Glimpse Into The Expert Outlook On Bristol-Myers Squibb Through 4 Analysts
Portfolio Pulse from Benzinga Insights
Analysts' ratings for Bristol-Myers Squibb (NYSE:BMY) over the last quarter show a range of sentiments from bullish to bearish. The average 12-month price target has decreased by 8.76%, with a current average target of $44.25. Recent analyst actions include maintaining neutral ratings and lowering price targets.
July 22, 2024 | 6:00 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Analysts' ratings for Bristol-Myers Squibb (NYSE:BMY) over the last quarter show mixed sentiments. The average 12-month price target has decreased by 8.76%, with a current average target of $44.25. Recent analyst actions include maintaining neutral ratings and lowering price targets.
The decrease in the average 12-month price target by 8.76% and the mixed sentiments from analysts suggest a negative short-term impact on Bristol-Myers Squibb's stock price. The lowered price targets and neutral ratings indicate concerns about the company's future performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100